Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-21-006402

Options or other derivatives

  • Chief Financial Officer acquired 382,046 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Green John L. Chief Financial Officer 2021-02-10 Grant or award · Stock Option (Right to Buy) +111,300 111,300 D
Green John L. Chief Financial Officer 2021-02-10 Grant or award · Stock Option (Right to Buy) +270,746 270,746 D
Loading xslF345X03/doc4.xml…